A global clinical research navigator

Clinical Trials Around the World

Explore a curated snapshot of registered cell and regenerative-medicine studies, then continue to the official registry to confirm recruitment, eligibility and study-site details.

Registry snapshot checked 8 November 2026Always confirm the current status with the listed study site.

26curated study records
17official registry gateways
7world regions represented
Curated registry snapshot

Find research by place, condition or status.

These records are selected for geographic and clinical breadth. They are not a complete inventory and do not indicate endorsement, safety, effectiveness or patient eligibility.

26 records shown

Study-wide and individual-site status may differ
RecruitingPhase 3
Australia + Canada + United States

exPDite-2: Bemdaneprocel for Parkinson's disease

Parkinson disease

Sponsor
BlueRock Therapeutics
Study locations
43 registry-listed locations; see official record for site status
Registry status verified
8 November 2026
Registry last updated
2026-11-02
NCT06944522 ยท View official record
RecruitingPhase 1 / Phase 2
United States

Q-Cells glial progenitor cells for transverse myelitis

Transverse myelitis

Sponsor
Q Therapeutics, Inc.
Study locations
University of Texas Southwestern Medical Center, Dallas
Registry status verified
8 November 2026
Registry last updated
2026-07-21
NCT03887273 ยท View official record
RecruitingPhase 1
United States

Delivery-device safety study for LCTOPC1 in spinal cord injury

Spinal cord injury

Sponsor
Lineage Cell Therapeutics, Inc.
Study locations
Rancho Research Institue, Downey; University of California, San Diego, La Jolla
Registry status verified
8 November 2026
Registry last updated
2026-02-12
NCT06841770 ยท View official record
RecruitingPhase 3
United States

CARTISTEM for knee cartilage lesions and osteoarthritis

Knee osteoarthritis

Sponsor
Medipost, Inc.
Study locations
37 registry-listed locations; see official record for site status
Registry status verified
8 November 2026
Registry last updated
2026-11-05
NCT07339111 ยท View official record
RecruitingPhase 2
United States

CATO: intravenous umbilical-cord stromal cells in ischemic cardiomyopathy

Ischemic cardiomyopathy

Sponsor
Roberto Bolli
Study locations
University of Miami Miller School of Medicine, Miami; University of Louisville School of Medicine, Institute of Molecular Cardiology, Louisville; The Texas Heart Institute Houston Texas, Houston
Registry status verified
8 November 2026
Registry last updated
2026-05-13
NCT06145035 ยท View official record
RecruitingPhase 1 / Phase 2
Canada

Umbilical-cord stromal cells in systemic sclerosis

Systemic sclerosis

Sponsor
Marie Hudson, MD
Study locations
Sir Mortimer B. Davis Jewish General Hospital, Montreal
Registry status verified
8 November 2026
Registry last updated
2026-02-03
NCT04356287 ยท View official record
Active, not recruitingPhase 2
Argentina + Austria + Belgium + Brazil + Canada + Denmark + France + Germany + Israel + Italy + Japan + Poland + Portugal + Spain + United Kingdom + United States

Breakfree-SLE: CD19-targeted CAR T cells for active lupus

SLE and lupus nephritis

Sponsor
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Study locations
97 registry-listed locations; see official record for site status
Registry status verified
8 November 2026
Registry last updated
2026-08-03
NCT07015983 ยท View official record
RecruitingNot applicable
Brazil

Autologous adipose stromal vascular fraction for type 2 diabetes

Type 2 diabetes

Sponsor
Kaiser Clinic and Hospital
Study locations
Kaiser Clinica, Sรฃo Jose Do Rio Preto
Registry status verified
8 November 2026
Registry last updated
2026-03-23
NCT07487467 ยท View official record
RecruitingPhase 1 / Phase 2
Thailand

MSC-derived extracellular vesicles for retinitis pigmentosa

Retinitis pigmentosa

Sponsor
Mahidol University
Study locations
Siriraj Hospital, Bangkok Noi
Registry status verified
8 November 2026
Registry last updated
2025-05-15
NCT06242379 ยท View official record
CompletedPhase 1 / Phase 2
Japan

iPSC-derived cardiomyocyte spheroids for severe ischemic heart failure

Ischemic heart failure

Sponsor
Heartseed Inc.
Study locations
8 registry-listed locations; see official record for site status
Registry status verified
8 November 2026
Registry last updated
2026-10-22
NCT04945018 ยท View official record
RecruitingPhase 3
South Korea

Cellgram-LC for alcohol-related liver cirrhosis

Liver cirrhosis

Sponsor
Pharmicell Co., Ltd.
Study locations
15 registry-listed locations; see official record for site status
Registry status verified
8 November 2026
Registry last updated
2026-09-21
NCT04689152 ยท View official record
RecruitingPhase 2
Taiwan

Umbilical-cord MSC infusion for moderate to severe COPD

COPD

Sponsor
Meribank Biotech Co., Ltd.
Study locations
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare, New Taipei City; Chang Gung Memorial Hospital, Linkou, Taoyuan City
Registry status verified
8 November 2026
Registry last updated
2024-07-08
NCT06491043 ยท View official record
RecruitingPhase 2 / Phase 3
Malaysia

Neuroncell-EX for acute ischemic stroke

Acute ischemic stroke

Sponsor
Cytopeutics Sdn. Bhd.
Study locations
Hospital Canselor Tuanku Muhriz UKM, Cheras
Registry status verified
8 November 2026
Registry last updated
2026-01-02
NCT06129175 ยท View official record
RecruitingPhase 1 / Phase 2
Indonesia

Umbilical-cord MSC therapy in diabetic nephropathy

Diabetic nephropathy

Sponsor
PT. Prodia Stem Cell Indonesia
Study locations
Dr. Sardjito General Hospital, Yogyakarta
Registry status verified
8 November 2026
Registry last updated
2026-02-09
NCT07396155 ยท View official record
RecruitingNot applicable
India

Autologous stromal vascular fraction for refractory perianal Crohn's disease

Crohn's disease

Sponsor
Asian Institute of Gastroenterology, India
Study locations
AIG Hospitals, Hyderabad; AIG Hospitals, Hyderabad
Registry status verified
8 November 2026
Registry last updated
2026-06-17
NCT07652632 ยท View official record
Active, not recruitingPhase 1
Israel

hOMSC300 oral-mucosa stem cells for multiple system atrophy

Multiple system atrophy

Sponsor
Cytora Ltd.
Study locations
Tel-Aviv Sourasky Medical Center (Ichilov), Tel Aviv
Registry status verified
8 November 2026
Registry last updated
2025-01-29
NCT05698017 ยท View official record
RecruitingPhase 2 / Phase 3
Egypt

Autologous insulin-producing mesenchymal stem cells for type 1 diabetes

Type 1 diabetes

Sponsor
Ain Shams University
Study locations
Children Hospital Eldemerdash, Cairo
Registry status verified
8 November 2026
Registry last updated
2025-04-30
NCT06951074 ยท View official record
RecruitingPhase 2
Italy

Neural stem-cell treatment for amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis

Sponsor
Casa Sollievo della Sofferenza IRCCS
Study locations
4 registry-listed locations; see official record for site status
Registry status verified
8 November 2026
Registry last updated
2024-04-03
NCT06344260 ยท View official record
RecruitingPhase 1 / Phase 2
France

Allogeneic adipose-derived MSCs for mild to moderate Alzheimer disease

Alzheimer disease

Sponsor
University Hospital, Toulouse
Study locations
University Hospital of Toulouse, Toulouse
Registry status verified
8 November 2026
Registry last updated
2026-06-23
NCT07367815 ยท View official record
RecruitingPhase 1 / Phase 2
Germany

iPSC-derived engineered human myocardium for terminal heart failure

Terminal heart failure

Sponsor
University Medical Center Goettingen
Study locations
University Medical Center Gรถttingen, Gรถttingen; Herz- und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen; University Medical Center Schleswig-Holstein, Lรผbeck
Registry status verified
8 November 2026
Registry last updated
2026-02-20
NCT04396899 ยท View official record
RecruitingPhase 1 / Phase 2
Denmark

Allogeneic mesenchymal stem cells for knee osteoarthritis

Knee osteoarthritis

Sponsor
Aarhus University Hospital
Study locations
Aarhus University, Aarhus N
Registry status verified
8 November 2026
Registry last updated
2024-06-11
NCT05933434 ยท View official record
Active, not recruitingPhase 1 / Phase 2
Spain + United Kingdom

RTX001 engineered macrophages for liver cirrhosis

Liver cirrhosis

Sponsor
Resolution Therapeutics Limited
Study locations
15 registry-listed locations; see official record for site status
Registry status verified
8 November 2026
Registry last updated
2026-10-05
NCT06823713 ยท View official record
RecruitingPhase 1
Greece + United States

Umbilical-cord or placental MSCs for spinal cord injury

Spinal cord injury

Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Study locations
Prodromos Stem Cell Institute, Naples; Prodromos Stem Cell Institute, Athens
Registry status verified
8 November 2026
Registry last updated
2026-10-20
NCT05152290 ยท View official record
Unknown; registry update overdueNot applicable
Turkey (Tรผrkiye)

Umbilical-cord MSC transplantation in infants with biliary atresia

Biliary atresia and liver fibrosis

Sponsor
Necmi KadฤฑoฤŸlu Hospital
Study locations
Esenyurt State Hospital, Istanbul
Registry status verified
8 November 2026
Registry last updated
2024-09-19
NCT06564740 ยท View official record
Active, not recruitingPhase 1
United States

Neural progenitor cells secreting GDNF for ALS

Amyotrophic lateral sclerosis

Sponsor
Cedars-Sinai Medical Center
Study locations
Cedars-Sinai Medical Center, Los Angeles
Registry status verified
8 November 2026
Registry last updated
2025-08-19
NCT05306457 ยท View official record
Active, not recruitingPhase 1
United States

Human embryonic-cell-derived MSCs for multiple sclerosis

Multiple sclerosis

Sponsor
ImStem Biotechnology
Study locations
Shepherd Center, Atlanta; UMass Memorial Medical Center, Worcester; Rocky Mountain MS Clinic, Salt Lake City
Registry status verified
8 November 2026
Registry last updated
2026-04-08
NCT04956744 ยท View official record
Go to the source

Official trial registries by region.

WHO-recognized primary registries and government databases provide the authoritative record. Use more than one registry when searching internationally.

Global search
Worldwide

WHO ICTRP Search Portal

Search records supplied by the WHO registry network and follow each result to its original registry.

Global registry
Worldwide

ClinicalTrials.gov

Search study status, sponsor, eligibility and individual study locations.

Regional registry
European Union / EEA

CTIS public search

Current medicinal-product trials under the EU Clinical Trials Regulation.

Primary registry
United Kingdom + international

ISRCTN

Plain-language summaries, protocols, results and study outputs.

Primary registry
Australia + New Zealand

ANZCTR

Interventional and observational studies with detailed recruitment filters.

Primary registry
Japan

jRCT

Regulated studies including dedicated regenerative-medicine classifications.

Primary registry
Republic of Korea

CRiS

Korean interventional and observational research in Korean and English.

Primary registry
India

CTRI

Clinical studies conducted in India with phase and recruitment filters.

Primary registry
Thailand

TCTR

Clinical trials and observational research conducted in Thailand.

Primary registry
China

ChiCTR

Search by condition, intervention, phase, city, hospital and recruitment status.

Primary registry
Brazil

ReBEC

Brazil-focused records available in Portuguese and English.

Regional registry
Africa

PACTR

Pan-African trial search with country, status and map filters.

Primary registry
Germany

DRKS

Interventional and observational studies with site and status search.

Primary registry
Iran + international

IRCT

Iranian WHO Primary Registry with advanced search.

Primary registry
Peru

REPEC

Authorized trials conducted in Peru, including historical records.

Primary registry
Sri Lanka

SLCTR

Sri Lankan trial records with progress reports.

Regulatory database
Canada

Health Canada CTDB

Authorized Phase Iโ€“III pharmaceutical and biological drug trials; โ€œongoingโ€ does not confirm recruitment.

Before contacting a study

A registry listing is a starting point, not proof of benefit.

Participation should begin with an official record, an active study contact and an informed-consent conversation you understand.

  1. 01

    Confirm the exact site

    A study may be recruiting overall while a location near you is closed or not yet open.

  2. 02

    Review eligibility and phase

    Read inclusion criteria, exclusions, study design, interventions and the purpose of the phase.

  3. 03

    Ask about consent and costs

    Informed consent is an ongoing conversation. Ask about risks, alternatives, travel, costs, privacy and your right to withdraw.

Share this resource

Help a patient, clinician or researcher find the official source.

For investigators and institutions

Share an officially registered study.

Submissions are reviewed by our editorial team before anything is considered for publication. An official public record is required; submissions are never published automatically.

  • Official registry or organizer URL
  • Public institutional contact details
  • Current status and verification date
Security check Required

Select the Stem Cell image to continue.

Delivered privately to info@stemcellthailand.org for manual review. Nothing is published automatically. Basic request IP and network-country information is included privately for spam screening.